Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

345 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
COVID-19 as a Potential Trigger for Immune Thrombotic Thrombocytopenic Purpura and Reason for an Unusual Treatment: A Case Report.
Schwaegermann MK, Hobohm L, Rausch J, Reuter M, Griemert TF, Sivanathan V, Falter T, Sprinzl MF, Lackner KJ, Galle PR, Konstantinides S, Theobald M, von Auer C. Schwaegermann MK, et al. Among authors: rausch j. Hamostaseologie. 2023 Jun;43(3):215-218. doi: 10.1055/a-1497-1054. Epub 2021 Jul 29. Hamostaseologie. 2023. PMID: 34327693 Free article.
Synergistic targeting of FLT3 mutations in AML via combined menin-MLL and FLT3 inhibition.
Dzama MM, Steiner M, Rausch J, Sasca D, Schönfeld J, Kunz K, Taubert MC, McGeehan GM, Chen CW, Mupo A, Hähnel P, Theobald M, Kindler T, Koche RP, Vassiliou GS, Armstrong SA, Kühn MWM. Dzama MM, et al. Among authors: rausch j. Blood. 2020 Nov 19;136(21):2442-2456. doi: 10.1182/blood.2020005037. Blood. 2020. PMID: 32589720 Free PMC article.
Treatment-Induced Aggravation of Vasculitis in Hairy-Cell Leukemia.
Rausch J, Windschmitt J, Schilling C, Butsch F, Theobald M, Sasca D, Hess G. Rausch J, et al. Clin Lymphoma Myeloma Leuk. 2021 May;21(5):e429-e431. doi: 10.1016/j.clml.2020.12.019. Epub 2020 Dec 23. Clin Lymphoma Myeloma Leuk. 2021. PMID: 33551343 No abstract available.
Menin inhibitor ziftomenib (KO-539) synergizes with drugs targeting chromatin regulation or apoptosis and sensitizes acute myeloid leukemia with MLL rearrangement or NPM1 mutation to venetoclax.
Rausch J, Dzama MM, Dolgikh N, Stiller HL, Bohl SR, Lahrmann C, Kunz K, Kessler L, Echchannaoui H, Chen CW, Kindler T, Döhner K, Burrows F, Theobald M, Sasca D, Kühn MWM. Rausch J, et al. Haematologica. 2023 Oct 1;108(10):2837-2843. doi: 10.3324/haematol.2022.282160. Haematologica. 2023. PMID: 37102614 Free PMC article. No abstract available.
Why do avian responses to change in Arctic green-up vary?
Tavera EA, Lank DB, Douglas DC, Sandercock BK, Lanctot RB, Schmidt NM, Reneerkens J, Ward DH, Bêty J, Kwon E, Lecomte N, Gratto-Trevor C, Smith PA, English WB, Saalfeld ST, Brown SC, Gates HR, Nol E, Liebezeit JR, McGuire RL, McKinnon L, Kendall S, Robards M, Boldenow M, Payer DC, Rausch J, Solovyeva DV, Stalwick JA, Gurney KEB. Tavera EA, et al. Among authors: rausch j. Glob Chang Biol. 2024 May;30(5):e17335. doi: 10.1111/gcb.17335. Glob Chang Biol. 2024. PMID: 38771086
345 results